en · de · es · pt
melanotan-2-notes.peptides8425.com › Guide › Storage, Verification And Regulatory Status — Research Overview

Storage, Verification And Regulatory Status — Research Overview

By Editorial Desk · published 2026-02-07 · last reviewed 2026-03-03 · Guide

A practical reference on reversed-phase HPLC: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2026-03-03 and is reviewed periodically as new material appears.

Storage, Verification and Regulatory Status

Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or oxidised impurities. Mass spectrometry, most often coupled to liquid chromatography, confirms molecular mass and detects substitutions that chromatography alone may miss. Amino acid analysis and peptide mapping supply additional structural evidence, while nuclear magnetic resonance is reserved for full structural confirmation. Laboratories that examine samples sold online report wide variation in actual content, with some vials containing little or none of the labelled material.

Melanotan-2 appears on the World Anti-Doping Agency prohibited list within the peptide hormone class, and several national regulators treat it as an unapproved prescription substance. Some countries restrict importation or sale for personal use. Because the compound is widely traded as a research chemical, the practical legal picture differs between jurisdictions and shifts over time. Human safety data covering long periods are limited, and whether repeated pigmentation changes carry any lasting risk to melanocytes remains an open question.

Background and Chemical Profile

The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.

Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.

Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.

Melanotan-2 at a glance

PropertyValueNotes
Typical storage temperature-20 °C or belowFor the lyophilised powder, desiccated
Storage formSealed vial, protected from lightAmber glass or foil-wrapped containers
Reconstituted stabilityShort, refrigerateDegradation accelerates in solution
Typical analytical methodReversed-phase HPLC with mass spectrometryPurity assessment plus identity confirmation
Common synonymsMelanotan II, MT-IIAlso written melanotan-2

Handling, Stability and Regulatory Status

Regulatory treatment varies by jurisdiction and has changed over time. In several countries the peptide is handled as an unapproved prescription medicine, and import or sale for human use is restricted, while elsewhere it falls under poisons or controlled-substance schedules. Enforcement activity against online vendors has been reported in Australia, New Zealand, the United Kingdom and the United States. Scholarly writing discusses melanotan-2 chiefly as an experimental tool and as a case study in unregulated peptide supply, and its precise legal position in any given country should be checked against current national schedules.

Lyophilised melanotan-2 is comparatively robust when kept dry, cold and dark, and a desiccated powder stored at minus twenty degrees Celsius or below is generally expected to retain its chemical integrity for extended periods. In solution the peptide is far less stable, with degradation proceeding through oxidation of tryptophan and histidine residues, hydrolysis adjacent to the lactam bridge, and aggregation at higher concentrations. Repeated freeze-thaw cycling accelerates loss of the parent peak. Working aliquots are therefore prepared once, held cold, and used without letting the stock return to ambient temperature.

Related pages on this site

Chemistry and Receptor Pharmacology

Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.

Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.

Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.

Notes from published material

The long-lasting session of parliament convened by King Stanisław August is known as the Great Sejm or Four-Year Sejm; it first met in 1788. Its landmark achievement was the passing of the Constitution of 3 May 1791, the first singular pronouncement of a supreme law of the state in modern Europe. A moderately reformist document condemned by detractors as sympathetic to the ideals of the French Revolution, it soon generated strong opposition from the conservative circles of the Commonwealth's upper nobility and from Empress Catherine of Russia, who was determined to prevent the rebirth of a strong Commonwealth. The nobility's Targowica Confederation, formed in Russian imperial capital of Saint Petersburg, appealed to Catherine for help, and in May 1792, the Russian army entered the territory of the Commonwealth. The Polish–Russian War of 1792, a defensive war fought by the forces of the Commonwealth against Russian invaders, ended when the Polish king, convinced of the futility of resistance, capitulated by joining the Targowica Confederation. The Russian-allied confederation took over the government, but Russia and Prussia in 1793 arranged for the Second Partition of Poland anyway. The partition left the country with a critically reduced territory that rendered it essentially incapable of an independent existence. The Commonwealth's Grodno Sejm of 1793, the last Sejm of the state's existence, was compelled to confirm the new partition.

Chicago, Illinois (includes Kenosha, Wisconsin) Clarksville, Tennessee Cincinnati, Ohio Columbia, Missouri Columbus, Ohio Dayton, Ohio Detroit, Michigan Indianapolis, Indiana Las Vegas, Nevada Lexington, Kentucky Louisville, Kentucky Minneapolis–St. Paul, Minnesota Nashville, Tennessee New York – New Jersey (includes Allentown, Pennsylvania) Orlando, Florida Phoenix, Arizona (no locations in Phoenix proper) St. Louis, Missouri Louisville and Columbus also house bulk-manufacturing (grocery-store sales, meat, and bun production) divisions. Company headquarters and the Porcelain Steel Buildings division are in Columbus, Ohio. In the late 20th century, White Castle tried expanding into three new cities, Philadelphia, Kansas City, and Cleveland-Akron. Those restaurants closed within several years. After a several decade hiatus, the company returned to the Kansas City area in 1985 only to leave again in 2001. White Castle entered the Cleveland-Akron area in 1987 and then exited in December 2014.

== History == Cell display systems were first used in 1985, when peptides were genetically fused with proteins displayed on the M13 bacteriophage. Bacteriophage display is a commonly used cell display system, although it carries limitations in the size of proteins that can be displayed. Bacterial display was then introduced in 1986, allowing the surface display of larger proteins. Bacterial display systems were first introduced by Freudl et al. and Charbit et al. in 1986, when they used bacterial surface proteins OmpA and LamB to display peptides. Freudl et al. fused peptides with linkers with the ompA gene, causing the peptides to be expressed in the OmpA proteins. They showed that the proteins were now subject to cleavage by proteinase K. The non-OmpA peptides inserted were therefore a target of proteinase K. Insertion of the foreign peptides did not affect bacterial cell growth. Charbit et al. firstly defined the areas of the LamB protein that were "permissive" for foreign petide insertion (ie that did not lead to a complete loss of functionality of the protein). Then, they explored the versatility of the permissive sites (size limit, nature of the epitope,...) that were all located in surface-exposed loops of the trimeric outer membrane porin, aiming at developing multivalent live bacterial vaccines. This was the first evidence of using bacterial surface display techniques to express proteins on the surface of cells, without altering the function of the cell.

==== Cell surface receptors ==== The extracellular environment is able to induce changes within the cell. Hormones, or other extracellular signals, are able to induce changes within the cell by binding to cell surface receptors also known as transmembrane receptors. This interaction allows the hormone receptor to produce second messengers within the cell to aid response. Second messengers may also be sent to interact with intracellular receptors in order to enter the complex signal transport system that eventually changes cellular function. G-protein-coupled membrane receptors (GPCR) are a major class of transmembrane receptors. The features of G proteins include GDP/GTP binding, GTP hydrolysis and guanosine nucleotide exchange. When a ligand binds to a GPCR the receptor changes conformation, which makes the intracellular loops between the different membrane domains of the receptor interact with G proteins. This interaction causes the exchange of GDP for GTP, which triggers structural changes within the alpha subunit of the G protein. The changes interrupts the interaction of the alpha subunit with the beta–gamma complex and which results in a single alpha subunit with GTP bound and a beta–gamma dimer. The GTP–alpha monomer interacts with a variety of cellular targets. The beta–gamma dimer also can stimulate enzymes within the cells for example, adenylate cyclase but it does not have as many targets as the GTP–alpha complex.

In 2006 and 2007, a series of studies provided arguably the first documented examples of de novo gene birth that did not involve overprinting. These studies were conducted using the accessory gland transcriptomes of Drosophila yakuba and Drosophila erecta and they identified 20 putative lineage-restricted genes that appeared unlikely to have resulted from gene duplication. Levine and colleagues identified and confirmed five de novo candidate genes specific to Drosophila melanogaster and/or the closely related Drosophila simulans through a rigorous approach that combined bioinformatic and experimental techniques. Since these initial studies, many groups have identified specific cases of de novo gene birth events in diverse organisms. The first de novo gene identified in yeast, BSC4 gene was identified in S. cerevisiae in 2008. This gene shows evidence of purifying selection, is expressed at both the mRNA and protein levels, and when deleted is synthetically lethal with two other yeast genes, all of which indicate a functional role for the BSC4 gene product. Historically, one argument against the notion of widespread de novo gene birth is the evolved complexity of protein folding. Interestingly, Bsc4 was later shown to adopt a partially folded state that combines properties of native and non-native protein folding. In plants, the first de novo gene to be functionally characterized was QQS, an Arabidopsis thaliana gene identified in 2009 that regulates carbon and nitrogen metabolism.

Sources: en.wikipedia.org

Further detail

Darlene made it up!" However, Barr had reportedly wanted to name the character David from the beginning, but the idea was rejected as Galecki was starring on another show, Billy as a character named David.

== Pharmacokinetics == Intramuscular cefodizime bioavailability ranges from 90% to 100%. It distributes into many tissues and is approximately 81% bound to plasma proteins, chiefly albumin. The drug reaches minimum inhibitory concentrations approximately 2–3 hours after administration, maintaining it for several hours afterwards. Clearance of cefodizime from the body is predominantly renal, with the majority of the drug excreted unchanged within the first 12 hours. More specifically, cefodizime is mainly cleared via glomerular filtration in the kidney, in addition to some tubular secretion. In patients with normal renal function, the terminal phase elimination half-life is approximately 3.5 hours.

Cotadutide is an experimental drug for the treatment of type 2 diabetes mellitus. It lowers blood glucose levels by mimicking the human hormones glucagon-like peptide 1 and glucagon, which play a role in blood sugar regulation. The drug is a peptide that is injected under the skin. Cotadutide is in Phase II clinical trials as of February 2021. Cotadutide, a therapeutic agent, was undergoing Phase II clinical trials. This stage of trials typically involves evaluating the drug's effectiveness and further assessing its safety in a larger group of participants, compared to earlier phases. Glucagon (medication)

=== Thorium-231 === 231Th has 141 neutrons. It is the decay product of uranium-235. It is found in very small amounts on the earth and has a half-life of 25.52 hours. When it decays, it emits a beta ray and forms protactinium-231, with a decay energy of 0.39 MeV.

== Mechanism == The nuclear force holding an atomic nucleus together is very strong, in general much stronger than the repulsive electromagnetic forces between the protons. However, the nuclear force is also short-range, dropping quickly in strength beyond about 3 femtometers, while the electromagnetic force has an unlimited range. The strength of the attractive nuclear force keeping a nucleus together is thus proportional to the number of the nucleons, but the total disruptive electromagnetic force of proton-proton repulsion trying to break the nucleus apart is roughly proportional to the square of its atomic number. A nucleus with 210 or more nucleons is so large that the strong nuclear force holding it together can just barely counterbalance the electromagnetic repulsion between the protons it contains. Alpha decay occurs in such nuclei as a means of increasing stability by reducing size. One curiosity is why alpha particles, helium nuclei, should be preferentially emitted as opposed to other particles like a single proton or neutron or other atomic nuclei. Part of the reason is the high binding energy of the alpha particle, which means that its mass is less than the sum of the masses of two free protons and two free neutrons. This increases the disintegration energy.

Sources: en.wikipedia.org

Background from the literature

When World War II broke out in 1939, the southern African territory of Southern Rhodesia had been a self-governing colony of the United Kingdom for 16 years, having gained responsible government in 1923. It was unique in the British Empire and Commonwealth in that it held extensive autonomous powers (including defence, but not foreign affairs) while lacking dominion status. In practice, it acted as a quasi-dominion, and was treated as such in many ways by the rest of the Commonwealth. Southern Rhodesia's white population in 1939 was 67,000, a minority of about 5%; the black population was a little over a million, and there were about 10,000 residents of coloured (mixed) or Indian ethnicity. The franchise was non-racial and in theory open to all, contingent on meeting financial and educational qualifications, but in practice very few black citizens were on the electoral roll. The colony's Prime Minister was Godfrey Huggins, a physician and veteran of World War I (1914–18) who had emigrated to Rhodesia from England in 1911 and held office since 1933. The territory's contribution to the British cause during World War I had been very large in proportion to its white population, though troops had been mostly raised from scratch as there had been no professional standing army beforehand. Since the start of self-government in 1923, the colony had organised the all-white Rhodesia Regiment into a permanent defence force, complemented locally by the partly paramilitary British South Africa Police (BSAP). The Rhodesia Regiment comprised about 3,000 men, including reserves, in 1938.

Wawrik, B; Paul, JH; Tabita, FR (2002). "Real-time PCR quantification of rbcL (ribulose-1,5-bisphosphate carboxylase/oxygenase) mRNA in diatoms and pelagophytes". Appl. Environ. Microbiol. 68 (8): 3771–3779. Bibcode:2002ApEnM..68.3771W. doi:10.1128/aem.68.8.3771-3779.2002. PMC 123995. PMID 12147471. Logan J; Edwards K; Saunders N, eds. (2009). Real-Time PCR: Current Technology and Applications. Caister Academic Press. ISBN 978-1-904455-39-4.

For services to Science. Roberta Diane Turley, lately Private Secretary, Nuclear Electric plc. For services to the Electricity Industry. Jean Venables, Director, Venables Consultancy Services. For services to Civil Engineering. Beryl Vickerton, Clerk, Atwick Parish Council. For services to Local Government. Christina Mary Waddell. For services to Victim Support and to Carers of Disabled People in Stirling. John Hill Waddell, lately Her Majesty's Inspector of Immigration for Scotland and Northern Ireland, Home Office. Peter Waddington. For services to the community in Downton, Wiltshire. Ann Cunningham Wagstaff, Executive Officer, Ministry of Defence. Geoffrey James George Wakeling, Senior Engineer, Leicestershire County Council. For services to Highways Improvement. Graham Basil Walker, Coxswain/Mechanic, Wells Lifeboat, Norfolk. For services to the Royal National Lifeboat Institution. Mary Walker, Chairman, General Committee of the Christie Hospital and Holt Radium Institute Women's Trust Fund. For charitable services. Nancy Hamilton Walker, Editor, Kinross Newsletter. For services to the community in Kinross-shire. Patricia Ann Walker, Valuation Referencer, Board of Inland Revenue. Sheila Mary Walker. For charitable services. Freda Inez Walley. For services to the community, particularly Prisoner Welfare, in Walsall. Valerie Ann Wallis, Vice-Chairman, Young Men's Christian Association. For services to Young People in Kent. John Wardrobe. For services to Association Football for Young People.

Ractopamine () is an animal feed additive used to promote leanness and increase food conversion efficiency in farmed animals in few countries, banned in most. Pharmacologically, it is a phenol-based TAAR1 agonist and β adrenoreceptor agonist that stimulates β1 and β2 adrenergic receptors. It is most commonly administered to animals for meat production as ractopamine hydrochloride. It is the active ingredient in products marketed in the US as Paylean for swine, Optaflexx for cattle, and Topmax for turkeys. It was developed by Elanco Animal Health, a former division of Eli Lilly and Company. As of 2025, the use of ractopamine "is banned or its use restricted in 168 nations", including the European Union, China and Russia, while it is legal in some other countries, with differing maximum residual limits (MRLs) in meat. Examples include the United States (50 ppb in pork, 30 ppb in beef); Japan, Taiwan and South Korea (10 ppb, in accordance with the Codex Alimentarius Commission); and New Zealand (0.1 ppb). Commercial ractopamine is a mixture of all four possible stereoisomers. It is also a positional isomer of dobutamine, a related drug.

=== Northern Ireland === During a debate with George Galloway in 2005, Hitchens revealed that he was "a lifelong supporter of the reunification of Ireland". Many times, when discussing "the Troubles" in Northern Ireland, Hitchens would refer to their location as simply "Ireland", rather than "Northern Ireland", as for example in an article written for Slate in 2007, discussing the power-sharing and devolved government in Northern Ireland and describing it as "an agreement to divide the spoils of Ireland's six northeastern counties". During the IRA bombing campaigns on Great Britain, which began in the 1970s, Hitchens claimed that he had "kept two sets of books: I didn't like bombs, I didn't like the partition of Ireland."

Sources: en.wikipedia.org

Frequently asked questions

How should the powder be stored?

The lyophilised solid is best kept cold, dry and dark, typically at minus twenty degrees Celsius. Moisture and repeated warming cycles are the main causes of degradation. Solutions prepared from the powder are less stable and are normally used quickly.

Which analytical methods confirm identity?

Reversed-phase liquid chromatography assesses purity, while mass spectrometry confirms molecular mass and detects sequence errors. Amino acid analysis and peptide mapping add structural detail. These techniques are complementary rather than interchangeable.

What is its status in sport and medicines?

It is listed as a prohibited peptide hormone by the World Anti-Doping Agency. No medicines regulator has approved it for human use. Import and sale rules vary by country.

What is melanotan-2?

It is a synthetic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone. It carries two non-natural substitutions and a cyclic bridge that increase its stability relative to the natural hormone. It circulates as a research chemical and is not an approved medicine.

Network